SGK
PFE icon

Steigerwald Gordon & Koch’s Pfizer PFE Stock Holding History

Steigerwald Gordon & Koch’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1M Sell
502,925
-15,955
-3% -$417K 1.2% 32
2026
Q1 		$14.6M Buy
518,880
+6,924
+1% +$184K 1.5% 26
2025
Q4 		$12.7M Buy
511,956
+3,222
+0.6% +$81.3K 1.22% 33
2025
Q3 		$13M Sell
508,734
-9,622
-2% -$237K 1.24% 34
2025
Q2 		$12.6M Buy
518,356
+9,690
+2% +$226K 1.33% 33
2025
Q1 		$12.9M Buy
508,666
+4,442
+0.9% +$116K 1.44% 31
2024
Q4 		$13.4M Buy
504,224
+46,760
+10% +$1.27M 1.51% 32
2024
Q3 		$13.2M Buy
457,464
+41,959
+10% +$1.22M 1.44% 36
2024
Q2 		$11.6M Buy
415,505
+175,657
+73% +$4.84M 1.41% 36
2024
Q1 		$6.66M Buy
239,848
+160,112
+201% +$4.44M 0.83% 43
2023
Q4 		$2.3M Buy
79,736
+57,668
+261% +$1.74M 0.31% 47
2023
Q3 		$732K Buy
22,068
+190
+0.9% +$6.72K 0.11% 65
2023
Q2 		$802K Buy
21,878
+476
+2% +$18.5K 0.12% 60
2023
Q1 		$873K Sell
21,402
-402
-2% -$17.4K 0.13% 57
2022
Q4 		$1.12M Buy
21,804
+521
+2% +$25K 0.18% 52
2022
Q3 		$931K Sell
21,283
-475
-2% -$23.1K 0.17% 56
2022
Q2 		$1.14M Buy
21,758
+4,342
+25% +$221K 0.2% 55
2022
Q1 		$902K Sell
17,416
-214
-1% -$11.1K 0.14% 62
2021
Q4 		$1.04M Buy
17,630
+408
+2% +$20.2K 0.16% 61
2021
Q3 		$741K Buy
17,222
+108
+0.6% +$4.78K 0.12% 64
2021
Q2 		$670K Sell
17,114
-291
-2% -$11.3K 0.11% 66
2021
Q1 		$631K Buy
17,405
+310
+2% +$11K 0.12% 68
2020
Q4 		$629K Buy
17,095
+521
+3% +$19.1K 0.13% 65
2020
Q3 		$577K Buy
16,574
+63
+0.4% +$2.21K 0.14% 61
2020
Q2 		$512K Buy
16,511
+727
+5% +$24.7K 0.14% 62
2020
Q1 		$489K Buy
15,784
+2,421
+18% +$82.5K 0.17% 60
2019
Q4 		$497K Buy
13,363
+6,021
+82% +$214K 0.12% 65
2019
Q3 		$250K Buy
7,342
+2
+0% +$73 0.06% 75
2019
Q2 		$302K Sell
7,340
-682
-9% -$27.1K 0.08% 69
2019
Q1 		$323K Sell
8,022
-1,983
-20% -$79.4K 0.09% 65
2018
Q4 		$414K Sell
10,005
-134
-1% -$5.56K 0.12% 58
2018
Q3 		$424K Buy
10,139
+16
+0.2% +$616 0.11% 60
2018
Q2 		$348K Buy
10,123
+1,917
+23% +$65.5K 0.09% 64
2018
Q1 		$276K Buy
8,206
+49
+0.6% +$1.69K 0.08% 70
2017
Q4 		$280K Sell
8,157
-5,015
-38% -$171K 0.08% 67
2017
Q3 		$446K Buy
13,172
+2,371
+22% +$76.2K 0.12% 51
2017
Q2 		$344K Buy
10,801
+222
+2% +$7K 0.1% 59
2017
Q1 		$343K Buy
10,579
+2,525
+31% +$79.6K 0.1% 56
2016
Q4 		$248K Buy
8,054
+40
+0.5% +$1.22K 0.08% 68
2016
Q3 		$258K Buy
8,014
+560
+8% +$18.7K 0.09% 59
2016
Q2 		$249K Buy
7,454
+14
+0.2% +$447 0.09% 57
2016
Q1 		$209K Buy
7,440
+448
+6% +$12.8K 0.08% 60
2015
Q4 		$214K Buy
6,992
+105
+2% +$3.3K 0.09% 56
2015
Q3 		$205K Hold
6,887
– – 0.09% 54
2015
Q2 		$219K Hold
6,887
– – 0.1% 49
2015
Q1 		$227K Hold
6,887
– – 0.11% 49
2014
Q4 		$204K Buy
+6,887
New +$197K 0.1% 50

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Steigerwald Gordon & Koch's PFE Position: Q2 2026 in Review

Steigerwald Gordon & Koch reduced its Pfizer (PFE) stake by 3.1% in Q2 2026, selling an estimated $417K and leaving 502,925 shares worth $12.1M. The position accounts for 1.2% of the portfolio, ranked #32.

Steigerwald Gordon & Koch first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $14.6M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Steigerwald Gordon & Koch held 502,925 shares of Pfizer worth $12.1M as of Q2 2026.
  • Steigerwald Gordon & Koch sold 15,955 Pfizer shares in Q2 2026, an estimated $417K.
  • Pfizer made up 1.2% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #32 holding.
  • Steigerwald Gordon & Koch first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
  • Steigerwald Gordon & Koch's Pfizer position peaked at $14.6M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.